Oestradiol patches: Estradiol TDP Mylan and Estradot will be your funded brands

What is changing?

The main funded brands of oestradiol patches are changing to Estradiol TDP Mylan (supplied by Viatris) and Estradot (supplied by Sandoz).

This means that, from 1 December 2025, everyone who uses funded oestradiol patches will need to use either the Estradiol TDP Mylan or Estradot brands. Estradiol TDP Mylan and Estradot will be the only funded brands of oestradiol patches from 1 December 2025. We understand most people are already using these brands.

Read the full decision: Decision to fund the Estradiol TDP Mylan and Estradot brands of oestradiol patches

Media release Pharmac to fund two brands of oestradiol patches from 1 December 2025

Estradiol TDP Mylan and Estradot are already available

Both Estradiol TDP Mylan and Estradot have been approved by Medsafe, this means they meet international standards for quality, effectiveness and safety. Estradiol TDP Mylan contains the same active ingredient, in the same quantities, as the Estradot brand of oestradiol patches. It is used in other countries, like the United States, already.

Medsafe datasheet: Estradiol transdermal patches (Mylan) [PDF](external link)

Estradot transdermal patches (Sandoz) [PDF](external link)

Supply status: All strengths and brands available

As at 13 June 2025, stock of all strengths and both brands is available. There is still a supply constraint affecting the Estradot brand. We will keep this page up to date if the availability of any patches changes.

There is still a global supply issue affecting Estradot patches

Pharmac has secured as much Estradot as the supplier can provide. However, there may be times when there is not enough Estradot for everyone who needs it.

The issues we’re experiencing are part of a global shortage of oestradiol patches. Demand for oestradiol patches has increased significantly in New Zealand and internationally, and the manufacturer of Estradot has not been able to produce enough to meet this growing demand.

This is not specific to New Zealand. Shortages are being experienced in many other countries, including Australia.

The patches limit and dispensing rules will remain

To help manage supply, both the Estradiol TDP Mylan and Estradot brands of oestradiol patches will continue to have a ‘2 patch per week’ limit on each strength. People will also continue to receive one month’s supply at a time from their pharmacy.

Maintaining the patch limit, and keeping monthly dispensing, will mean that more people will have access to the strength of Estradot patches they need. Changing or removing these limits would put pressure on demand, which would increase the risk of these patches not being available.

Pharmac will review the patch limit and dispensing rules in 12 months depending on the supply outlook.

What does this mean for people using oestradiol patches?

From 1 December 2025, your pharmacy is likely to start giving you the Estradiol TDP Mylan brand of oestradiol patches. The Estradot brand of oestradiol patches may also be available if you, or your prescriber request it.

So that the people who need Estradot can get it, we are asking you to use Estradiol TDP Mylan if you can. You can ask your pharmacist to dispense the Estradiol TDP Mylan brand for you.

From 1 December 2025, the Estradiol TDP Mylan and Estradot brands of oestradiol patches will be the only funded brands.

Information for pharmacists

So that there is enough stock of Estradot for the people who need it, please consider dispensing the Estradiol TDP Mylan brand for prescriptions written generically.

You will need to stock both the Estradiol TDP Mylan and Estradot brands of oestradiol patches.

Brand switch fee

A Brand Switch Fee will apply to the Estradiol TDP Mylan brand from 1 December 2025 until 28 February 2026.

Printed flyer

You asked for a pre-printed resource to give to people affected by this decision. We aim to have an ordering portal up shortly that you can order flyers from. We will alert you when it's ready through our weekly supply issues email.

Subscribe to receive the supply issues email(external link)

In the meantime, the flyer is available to download [PDF, 79 KB] 

Information for prescribers

Please note on the prescription a person’s preferred brand of oestradiol patches.

So that there is enough stock of Estradot for the people who need it, we are asking you to consider prescribing:

• the Estradiol TDP Mylan brand of oestradiol patches for people starting treatment.
• the Estradiol TDP Mylan brand of oestradiol patches for people who are already using it without concern.
• the Estradot brand of oestradiol patches for people who need it.

Who to contact

If you have any questions about our decision or the funding arrangements, email us on enquiry@pharmac.govt.nz